CME – docShepherd

Opioid or Other Substance Use Disorder – FreeTraining Resources

June 5, 2023 dashephe

Opioid or Other Substance Use Disorder – FreeTraining Resources Removal of DATA Waiver (X-Waiver) Requirement | SAMHSA Explains the DEA 8-hour educational requirement that starts June 27, 2023 AMA: Substance…

Education

CME; Aducanumab, lecanemab, gantenerumab, mild cognitive

February 20, 2023 dashephe

https://reachmd.com/programs/cme/advancing-alzheimers-disease/14648/?autoplay=1&utm_source=30&utm_medium=20&utm_campaign=748483&utm_brand=1&utm_segment=0

Enter your email Address

Dementia Journal - Teepa Snow

JAMDA

Opioid or Other Substance Use Disorder – FreeTraining Resources

CME; Aducanumab, lecanemab, gantenerumab, mild cognitive

You missed

Surveyor Guidance Update 11-18-24

Assessment of Behavioral/Psychological Symptoms of Dementia Guidelines and Implementation | Psychiatry Online

Pain Assessment Information | GeriatricPain.org – The University of Iowa

Candida auris outbreak in a long-term acute care hospital | November 15, 2024

Enter your email Address

Tag: CME

Opioid or Other Substance Use Disorder – FreeTraining Resources

CME; Aducanumab, lecanemab, gantenerumab, mild cognitive

You missed

Surveyor Guidance Update 11-18-24

Assessment of Behavioral/Psychological Symptoms of Dementia Guidelines and Implementation | Psychiatry Online

Pain Assessment Information | GeriatricPain.org – The University of Iowa

Candida auris outbreak in a long-term acute care hospital | November 15, 2024